Literature DB >> 22924455

Increased phospho-mTOR expression in megakaryocytic cells derived from CD34+ progenitors of essential thrombocythaemia and myelofibrosis patients.

Luisa Vicari1, Daniela Martinetti, Simona Buccheri, Cristina Colarossi, Eleonora Aiello, Fabio Stagno, Loredana Villari, Maide Cavalli, Francesco Di Raimondo, Massimo Gulisano, Ruggero De Maria, Paolo Vigneri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22924455     DOI： 10.1111/j.1365-2141.2012.09246.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  7 in total

Review 1.  Preclinical models for drug selection in myeloproliferative neoplasms.

Authors:  Niccolò Bartalucci; Costanza Bogani; Alessandro M Vannucchi
Journal:  Curr Hematol Malig Rep       Date:  2013-12       Impact factor: 3.952

2.  Effect of trehalose on cryopreservation of pure peripheral blood stem cells.

Authors:  Daniela Martinetti; Cristina Colarossi; Simona Buccheri; Gabriella Denti; Lorenzo Memeo; Luisa Vicari
Journal:  Biomed Rep       Date:  2017-02-14

Review 3.  JAK kinase targeting in hematologic malignancies: a sinuous pathway from identification of genetic alterations towards clinical indications.

Authors:  Lorraine Springuel; Jean-Christophe Renauld; Laurent Knoops
Journal:  Haematologica       Date:  2015-10       Impact factor: 9.941

4.  Microarray and Proteomic Analyses of Myeloproliferative Neoplasms with a Highlight on the mTOR Signaling Pathway.

Authors:  Vladan P Čokić; Pascal Mossuz; Jing Han; Nuria Socoro; Bojana B Beleslin-Čokić; Olivera Mitrović; Tijana Subotički; Miloš Diklić; Danijela Leković; Mirjana Gotić; Raj K Puri; Constance Tom Noguchi; Alan N Schechter
Journal:  PLoS One       Date:  2015-08-14       Impact factor: 3.240

5.  Inhibitors of the PI3K/mTOR pathway prevent STAT5 phosphorylation in JAK2V617F mutated cells through PP2A/CIP2A axis.

Authors:  Niccolò Bartalucci; Laura Calabresi; Manjola Balliu; Serena Martinelli; Maria Caterina Rossi; Jean Luc Villeval; Francesco Annunziato; Paola Guglielmelli; Alessandro M Vannucchi
Journal:  Oncotarget       Date:  2017-05-22

6.  Curcumin induces apoptosis in JAK2-mutated cells by the inhibition of JAK2/STAT and mTORC1 pathways.

Authors:  Jessica Petiti; Valentina Rosso; Marco Lo Iacono; Cristina Panuzzo; Chiara Calabrese; Elisabetta Signorino; Lucrezia Pironi; Antonio Cartellà; Enrico Bracco; Barbara Pergolizzi; Tiziana Beltramo; Carmen Fava; Daniela Cilloni
Journal:  J Cell Mol Med       Date:  2019-04-29       Impact factor: 5.310

7.  Co-targeting the PI3K/mTOR and JAK2 signalling pathways produces synergistic activity against myeloproliferative neoplasms.

Authors:  Niccolò Bartalucci; Lorenzo Tozzi; Costanza Bogani; Serena Martinelli; Giada Rotunno; Jean-Luc Villeval; Alessandro M Vannucchi
Journal:  J Cell Mol Med       Date:  2013-11-17       Impact factor: 5.310
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.